学会発表
進行・再発乳癌におけるリアルワールドエビデンスの課題と展望
相良安昭
第31回日本乳癌学会学術総会, 2023 Jun, Yokohama (シンポジウム）
乳癌における包括的ゲノム診療の実際-JBCRG REIWA studyを通して-
増田紘子, 多田寛, 服部正也, 古川孝広, 原文堅, 田辺裕子, 相良安昭, 北川大, 枝園忠彦, 岩谷胤生, 八十島宏行, 上本康明, 吉村健一, 岩田広治, 増田慎三
第31回日本乳癌学会学術総会, 2023 Jun, Yokohama (シンポジウム)
Pertuzumab retreatment in patients with HER2-positive locally advanced/ metastatic breast cancer: Overall survival results of a phase III randomized trial (JBCRG-M05: PRECIOUS).
Yutaka Yamamoto, Hiroji Iwata, Masato Takahashi, Tetsuhiro Yoshinami, Takayuki Ueno, Tatsuya Toyama, Takashi Yamanaka, Toshimi Takano, Masahiro Kashiwaba, Koichiro Tsugawa, Yoshie Hasegawa, Kenji Tamura, Hiroshi Tada, Fumikata Hara, Naruto Taira, Shigehira Saji, Satoshi Morita, Masakazu Toi, Shinji Ohno, Norikazu Masuda
ASCO, 2023 Jun, Chigago USA (Poster Discussion Session)
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1+P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: JBCRG20 study (Neo-peaks)
Kenichi Inoue, Norikazu Masuda, Toshimi Takano, Mitsuya Ito, Yuko Tanabe, Kosuke Kawaguchi, Hiroyuki Yasojima, Hiroko Bando, Rikiya Nakamura, Takashi Yamanaka, Kazushige Ishida, Tomoyuki Aruga, Yasuhiro Yanagita, Eriko Tokunaga, Kenjiro Aogi, Shinji Ohno, Hiroi Kasai, Tatsuki R. Kataoka, Satoshi Morita, Masakazu Toi
ESMO Breast Cancer, 2023 May, Berlin Germany (Mini Oral)
Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer Initial Results from the POSITIVE Trial
Ann H Partridge, Samuel M Niman, Monica Ruggeri, Fedro A Peccatori, Hatem A Azim Jr, Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna B Sætersdal, Judith R Kroep, Audrey Mailliez, Ellen Warner, Virginia F Borges, Frédéric Amant, Andrea Gombos, Akemi Kataoka, Christine Rousset-Jablonski, Simona Borstnar, Junko Takei, Jeong E Lee, Janice M Walshe, Manuel Ruíz-Borrego, Halle C F Moore, Christobel Saunders, Vesna Bjelic-Radisic, Snezana Susnjar, Fatima Cardoso, Karen L Smith, Teresa Ferreiro, Karin Ribi, Kathryn Ruddy, Sarra El-Abed, Martine Piccart, Larissa A Korde, Aron Goldhirsch, Richard D Gelber, Olivia Pagani
SABCS, 2022 Dec, Texas USA (Oral)
Retrospective study using database for the effectiveness of medroxyprogesterone acetate in patients with ER-positive/HER2-negative postmenopausal advanced breast cancer: An additional analysis of the JBCRG-C06 Safari study
Kaho Utsunomiya, Hidetoshi Kawaguchi, Yutaka Yamamoto, Shigehira Saji, Norikazu Masuda, Takahiro Nakayama, Kenjiro Aogi, Keisei Anan, Shoichiro Ohtani, Nobuaki Sato, Toshimi Takano, Eriko Tokunaga, Seigo Nakamura, Yoshie Hasegawa, Masaya Hattori, Tomomi Fujisawa, Satoshi Morita, Miki Yamaguchi, Toshinari Yamashita, Daisuke Yotsumoto, Masakazu Toi and Shinji Ohno
2022.12 SABCS Poster San Antonio, Texas
転移・再発乳癌における遺伝子パネル検査の観察研究REIWA studyの中間解析
Hiroko Masuda, Hiroshi Tada, Yayoi Adachi, Tsuguo Iwatani, Yasuaki Uemoto, Dai Kitagawa, Takahiro Kogawa, Yasuaki Sagara, Tadahiko Shien, Fumikata Hara, Hiroyuki Yasojima, Kenichi Yoshimura, Hiroji Iwata, Norikazu Masuda
第60回日本癌治療学会学術集会 2022年10月
Interim report of a prospective, multicenter observational study of atezolizumab in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE
Yumi Fujimoto, Tatsunori Shimoi, Nobuhiro Shibata, Yukio Koibuchi, Naoki Hashimoto, Jun Yamamura, Takashi Morimoto, Michiko Tsuneizumi, Tetsuhiko Taira, Hiroshi Tada, Takashi Yamanaka, Mari S. Oba, Kouji Takahashi, Norikazu Masuda, Naoki Niikura
第60回日本癌治療学会学術集会, 2022 Oct, Kobe (Oral)
Fulvestrant with additional palbociclib in advanced or metastatic hormone receptor-positive HER2-negative breast cancer after progression to fulvestrant monotherapy: JBCRG- M07 (FUTURE trial)
Kenichi Watanabe, Naoki Niikura, Yuichiro Kikawa, Mari Oba, Kokoro Kobayashi, Hiroshi Tada, Shinji Ozaki, Uhi Toh, Yutaka Yamamoto, Michiko Tsuneizumi, Toshitaka Okuno, Nobutaka Iwakuma, Takeshi Takeshita, Takayuki Iwamoto, Hiroshi Ishiguro, Norikazu Masuda, Shigehira Saji
2022.9 ESMO Poster WEB
Time-series cytokine profiles correlate with treatment responses and HRD in TNBC
Kosuke Kawaguchi, Don Pietro Saldajeno, Shinpei Kawaoka, Sunao Tanaka, Hiroko Bando, Tomomi Nishimura, Takayuki Kadoya, Takashi Yamanaka, Shigeru Imoto, Ravindranath M. Velaga, Yurina Maeshima, Masahiro Takada, Takayuki Ueno, Hiroshi Ishiguro, Seishi Ogawa, Hironori Haga, Shinji Ohno, Satoshi Morita, Norikazu Masuda, Masakazu Toi
2022年7月 第30回日本乳癌学会学術総会 厳選口演 ハイブリッド